NKF Spring Clinical Meetings 2019

Cancer Incidence Higher in Patients with CKD

Boston—In the United States, cancer is a leading cause of morbidity and mortality. Further, an estimated one in three Americans is at risk for chronic kidney disease (CKD). There are data from previous studies on the risk of certain cancers in patients on dialysis; however, studies on the incidence of cancer in patients with CKD are limited. Jagadeesh Puvvula, PharmD, ... Read More »

Scheduling Algorithm Improves Efficiency of Resources

Boston—At a large dialysis provider, nurses are assigned to have in-person assessment of patients identified as high risk for poor outcomes. The care coordination unit makes the assignments utilizing assessments made during the patient’s regularly scheduled dialysis treatments; the assessments serve as additional check-in on the patient’s health and well-being. Many hours of work each week are required to identify ... Read More »

Adverse Clinical Events in Patients on Maintenance Dialysis

Boston—Clinical adverse events among patients with end-stage renal disease (ESRD) on maintenance dialysis are uncommon. However, according to Dustin Little, MD, and colleagues, an improved understanding of the rates of adverse events in that patient population could be of benefit to patients, providers, and other stakeholders. Utilizing data from the US Renal Data System, the researchers conducted a retrospective cohort ... Read More »

AKI Following Arthroplasty in Transplant Recipients

Boston—Secondary bone complications such as avascular necrosis/osteoporosis are common among transplant recipients. Arthroplasty is the usual treatment of choice. However, acute kidney injury (AKI) often occurs during total arthroplasty, with incidence rates among transplant recipients from 16% to 26%; incidence rates in the general population are as low as 1.1%. There are few data on the underlying reasons why kidney ... Read More »

Access to Care for Hemodialysis Patients During Natural Disasters

Boston—Among patients dependent on renal replacement therapy, the effects of missed treatments are severe, making access to care for in-center hemodialysis patients critical during and after a natural disaster. Stephanie Baterseh (United Kingdom) and Vijay Lapsia, MD, (United States) conducted a review of existing literature to examine the state of the art in managing care of dialysis patients in the ... Read More »

Awareness of Proteinuria in the Community Setting: KDSAP Results

Boston—The Kidney Disease Screening and Awareness Program (KDSAP), working to increase early detection and improve awareness of kidney disease, provides free screening and education in the community setting. Proteinuria is an independent predictor of adverse clinical outcomes, yet due to the asymptomatic nature of proteinuria, early recognition is difficult; most individuals with proteinuria are not aware they have this condition. ... Read More »

AKI Incidence in Patients Undergoing Total Hip Arthroplasty

Boston—Worldwide, the number of total hip arthroplasties being performed is increasing rapidly. Sohail Abdul Salim, MD, and colleagues recently conducted a literature search and meta-analysis to examine the incidence of acute kidney injury (AKI) in patients undergoing the procedure. They reported results of the meta-analysis during a poster session at the NKF Spring Clinical Meetings in a poster titled Incidence ... Read More »

Late-Breaker: Primary Results of AMBER: Patiromer plus Spironolactone for Blood Pressure Management

Boston—Treatment-resistant hypertension is a common complication of chronic kidney disease (CKD), yet the use of renin-angiotensin-aldostyerone system inhibitor (RAASi) drugs may be limited in patients with CKD due to hyperkalemia. The PATHWAY-2 trial demonstrated that spironolactone was an effective fourth-line therapy for treatment-resistant hypertension; however, patients with advanced CKD were excluded from that trial. The phase 2 AMBER study was ... Read More »

Cost-Effectiveness of Treatments for Anemia in CKD

Boston—For patients with chronic kidney disease (CKD) with anemia, clinical guidelines recommend erythropoietin-stimulating agents (ESA), oral or intravenous (IV) iron, or red blood cell transfusions. The treatment recommendations depend on hemoglobin level and prior treatment. The economic implications of the treatment decisions are uncertain. Tara Lavelle, PhD, and colleagues recently conducted a review of published cost-effective analyses to improve understanding ... Read More »

Association of Gestational Diabetes and CKD by Race/Ethnicity

Boston—Diabetes is a leading cause of chronic kidney disease (CKD). Women who develop gestational diabetes are at increased risk for diabetes and thus for CKD. Non-white women are at increased risk for diabetes, albuminuria, and progression of CKD compared with non-Hispanic white women. Joanne Rodrigue, MPH, and colleagues conducted an analysis to examine the link between gestational diabetes and CKD ... Read More »